Moolec Science (MLEC) Retained Earnings (2022 - 2025)
Moolec Science (MLEC) reported Retained Earnings of -$44.6 million for Q4 2025, up 36.58% on a YoY basis from -$32.6 million in Q4 2024, and up 60.13% sequentially from -$111.8 million in Q2 2025.
Moolec Science (MLEC) Retained Earnings (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Retained Earnings data on file, last reported at -$44.6 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 36.58% year-over-year to -$44.6 million; the trailing twelve-month figure through Dec 2025 stood at -$44.6 million (up 36.58% YoY), and the FY2025 full-year result was -$111.8 million, down 9882.57% from the prior year.
- Retained Earnings rose to -$44.6 million in Q4 2025, from -$111.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.1 million in Q2 2024 to a low of -$111.8 million in Q2 2025.
- A 4-year average of -$54.5 million and a median of -$60.2 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 101.95% in 2024 and plunged 9882.57% in 2025, its largest moves.
- Tracing MLEC's Retained Earnings over 4 years: stood at -$55.5 million in 2022, then dropped by 11.67% to -$62.0 million in 2023, then slipped by 13.36% to -$70.3 million in 2024, then jumped by 36.58% to -$44.6 million in 2025.
- Business Quant data shows MLEC's Retained Earnings at -$44.6 million in Q4 2025, -$111.8 million in Q2 2025, and -$70.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -44.57 Mn |
| Jun 30, 2025 | -111.79 Mn |
| Dec 31, 2024 | -70.28 Mn |
| Sep 30, 2024 | -67.85 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | -63.40 Mn |
| Dec 31, 2023 | -62.00 Mn |
| Sep 30, 2023 | -60.21 Mn |
| Jun 30, 2023 | -58.62 Mn |
| Dec 31, 2022 | -55.52 Mn |
| Jun 30, 2022 | -6.83 Mn |